Johan F. Vansteenkiste

Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia

Laurent Bastit, A. Vandebroek, Sevilay Altıntaş et al. · Journal of Clinical Oncology · 2008 · 195 citations · Full text

Medicine, Hematology, Pharmacology +17

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

Nicholas Thatcher, E S De Campos, David Bell et al. · British Journal of Cancer · 1999 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide

Robert Pirker, Rodryg Ramlau, Wolfgang Schuette et al. · Journal of Clinical Oncology · 2008 · 115 citations

Medicine, Oncology, Pharmacology +12

Intravenous Iron Supplementation for the Treatment of Cancer-Related Anemia – Systematic Review and Meta-Analysis

Anat Gafter‐Gvili, Benaya Rozen‐Zvi, Liat Vidal et al. · Blood · 2010 · 12 citations

Medicine, Hematology, Oncology +14